fda on tirzepatide The @U.S. Food and Drug Administration (@fda ) has accepted @Sandoz 's applications for review of two generic versions of tirzepatide, the active ingredient in Eli Lilly and Company 's blockbuster drugs FDA's tirzepatide decision creates uncertainty
Pay in 4 interest-free payments of $5.01 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28






















:max_bytes(150000):strip_icc()/Health-GettyImages-2153927815-0bf99cd73e2c46908d7fc0973739f6d0.jpg)